Revagenix

Revagenix is committed to creating life-changing antibiotics and providing urgently needed anti-infective drugs for patients worldwide. We are advancing a focused pipeline aimed at treating infections caused by multidrug-resistant organisms. The team consists of seasoned industry experts and is supported by world-class strategic partners, collaborators, investors, and advisors, leveraging extensive experience in anti-infective research, development, and commercialization. Together, we are developing the next generation of antibiotics to address the growing urgency for new therapies in response to increasing antibiotic resistance.